BR112015005467A2 - métodos de tratar condições relacionadas ao cabelo - Google Patents
métodos de tratar condições relacionadas ao cabeloInfo
- Publication number
- BR112015005467A2 BR112015005467A2 BR112015005467A BR112015005467A BR112015005467A2 BR 112015005467 A2 BR112015005467 A2 BR 112015005467A2 BR 112015005467 A BR112015005467 A BR 112015005467A BR 112015005467 A BR112015005467 A BR 112015005467A BR 112015005467 A2 BR112015005467 A2 BR 112015005467A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- pharmaceutically acceptable
- patient
- related conditions
- treating hair
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 210000004209 hair Anatomy 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000004384 Alopecia Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 231100000360 alopecia Toxicity 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 210000003780 hair follicle Anatomy 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261700623P | 2012-09-13 | 2012-09-13 | |
| PCT/EP2013/069062 WO2014041140A1 (en) | 2012-09-13 | 2013-09-13 | Methods of treating hair related conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015005467A2 true BR112015005467A2 (pt) | 2017-07-04 |
Family
ID=49170707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015005467A BR112015005467A2 (pt) | 2012-09-13 | 2013-09-13 | métodos de tratar condições relacionadas ao cabelo |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US20150250749A1 (enExample) |
| EP (1) | EP2895160B1 (enExample) |
| JP (1) | JP2015528479A (enExample) |
| KR (1) | KR20150054934A (enExample) |
| CN (1) | CN104837486A (enExample) |
| AU (1) | AU2013314288B2 (enExample) |
| BR (1) | BR112015005467A2 (enExample) |
| CA (1) | CA2883823A1 (enExample) |
| CY (1) | CY1120793T1 (enExample) |
| DK (1) | DK2895160T3 (enExample) |
| EA (1) | EA035986B1 (enExample) |
| ES (1) | ES2675169T3 (enExample) |
| HR (1) | HRP20181000T1 (enExample) |
| HU (1) | HUE037903T2 (enExample) |
| IL (1) | IL237449A0 (enExample) |
| IN (1) | IN2015DN02104A (enExample) |
| LT (1) | LT2895160T (enExample) |
| MX (1) | MX356888B (enExample) |
| NZ (1) | NZ705389A (enExample) |
| PL (1) | PL2895160T3 (enExample) |
| PT (1) | PT2895160T (enExample) |
| SI (1) | SI2895160T1 (enExample) |
| TR (1) | TR201809219T4 (enExample) |
| UA (1) | UA116215C2 (enExample) |
| WO (1) | WO2014041140A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
| PT2396081T (pt) | 2009-02-16 | 2017-07-11 | Nogra Pharma Ltd | Compostos alquilamido e suas utilizações |
| EP2811993B1 (en) | 2012-02-09 | 2019-10-09 | Nogra Pharma Limited | Methods of treating fibrosis |
| IN2014DN08157A (enExample) | 2012-04-18 | 2015-05-01 | Nogra Pharma Ltd | |
| SI3921299T1 (sl) | 2019-02-08 | 2025-03-31 | Nogra Pharma Limited | Postopek izdelave 3-(4'-aminofenil)-2-metoksipropionske kisline in njenih analogov in vmesnih proizvodov |
| WO2025132838A1 (en) * | 2023-12-20 | 2025-06-26 | Nogra Pharma Limited | Acne topical formulations |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2396081T (pt) * | 2009-02-16 | 2017-07-11 | Nogra Pharma Ltd | Compostos alquilamido e suas utilizações |
| IN2014DN08157A (enExample) * | 2012-04-18 | 2015-05-01 | Nogra Pharma Ltd |
-
2013
- 2013-09-13 LT LTEP13762485.4T patent/LT2895160T/lt unknown
- 2013-09-13 EP EP13762485.4A patent/EP2895160B1/en active Active
- 2013-09-13 HR HRP20181000TT patent/HRP20181000T1/hr unknown
- 2013-09-13 NZ NZ705389A patent/NZ705389A/en not_active IP Right Cessation
- 2013-09-13 PL PL13762485T patent/PL2895160T3/pl unknown
- 2013-09-13 CA CA2883823A patent/CA2883823A1/en not_active Abandoned
- 2013-09-13 BR BR112015005467A patent/BR112015005467A2/pt active Search and Examination
- 2013-09-13 DK DK13762485.4T patent/DK2895160T3/en active
- 2013-09-13 WO PCT/EP2013/069062 patent/WO2014041140A1/en not_active Ceased
- 2013-09-13 TR TR2018/09219T patent/TR201809219T4/tr unknown
- 2013-09-13 AU AU2013314288A patent/AU2013314288B2/en not_active Ceased
- 2013-09-13 US US14/428,164 patent/US20150250749A1/en not_active Abandoned
- 2013-09-13 UA UAA201503407A patent/UA116215C2/uk unknown
- 2013-09-13 CN CN201380047941.4A patent/CN104837486A/zh active Pending
- 2013-09-13 EA EA201590546A patent/EA035986B1/ru not_active IP Right Cessation
- 2013-09-13 SI SI201331087T patent/SI2895160T1/sl unknown
- 2013-09-13 JP JP2015531580A patent/JP2015528479A/ja active Pending
- 2013-09-13 MX MX2015003278A patent/MX356888B/es active IP Right Grant
- 2013-09-13 HU HUE13762485A patent/HUE037903T2/hu unknown
- 2013-09-13 IN IN2104DEN2015 patent/IN2015DN02104A/en unknown
- 2013-09-13 KR KR1020157009052A patent/KR20150054934A/ko not_active Withdrawn
- 2013-09-13 ES ES13762485.4T patent/ES2675169T3/es active Active
- 2013-09-13 PT PT137624854T patent/PT2895160T/pt unknown
-
2015
- 2015-02-26 IL IL237449A patent/IL237449A0/en unknown
-
2018
- 2018-06-28 CY CY20181100673T patent/CY1120793T1/el unknown
-
2020
- 2020-06-04 US US16/892,513 patent/US20210113505A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2883823A1 (en) | 2014-03-20 |
| AU2013314288A1 (en) | 2015-03-19 |
| MX356888B (es) | 2018-06-18 |
| ES2675169T3 (es) | 2018-07-09 |
| CY1120793T1 (el) | 2020-05-29 |
| UA116215C2 (uk) | 2018-02-26 |
| LT2895160T (lt) | 2018-07-10 |
| WO2014041140A1 (en) | 2014-03-20 |
| EP2895160A1 (en) | 2015-07-22 |
| IN2015DN02104A (enExample) | 2015-08-14 |
| US20150250749A1 (en) | 2015-09-10 |
| NZ705389A (en) | 2018-08-31 |
| PL2895160T3 (pl) | 2018-09-28 |
| US20210113505A1 (en) | 2021-04-22 |
| DK2895160T3 (en) | 2018-06-25 |
| SI2895160T1 (sl) | 2018-09-28 |
| JP2015528479A (ja) | 2015-09-28 |
| EA201590546A1 (ru) | 2015-08-31 |
| MX2015003278A (es) | 2015-07-06 |
| EA035986B1 (ru) | 2020-09-09 |
| CN104837486A (zh) | 2015-08-12 |
| HRP20181000T1 (hr) | 2018-09-21 |
| IL237449A0 (en) | 2015-04-30 |
| TR201809219T4 (tr) | 2018-07-23 |
| KR20150054934A (ko) | 2015-05-20 |
| PT2895160T (pt) | 2018-06-29 |
| EP2895160B1 (en) | 2018-05-30 |
| AU2013314288B2 (en) | 2018-07-05 |
| HUE037903T2 (hu) | 2018-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015005467A2 (pt) | métodos de tratar condições relacionadas ao cabelo | |
| BR112013011184A2 (pt) | composições e métodos para tratamento de mielofibrose | |
| BR112015008447A2 (pt) | métodos para tratar câncer | |
| DOP2015000240A (es) | 3- pirimidin- 4- il- oxazolidin- 2- onas como inhibidores de idh mutante | |
| BR112015014458A2 (pt) | derivados de manose para o tratamento de infecções bacterianas | |
| BR112014032809A8 (pt) | urolitinas, usos de uma quantidade eficaz de uma urolitina ou um sal farmaceuticamente aceitável da mesma e composição compreendendo as mesmas | |
| BR112015012366A8 (pt) | antagonistas de cxcr7, uso dos mesmos, composição farmacêutica, bem como métodos para detectar níveis elevados de cxcr7 em uma amostra e para imagear um tumor, órgão, ou tecido | |
| MX343685B (es) | Compuestos de benceno substituidos con arilo o heterorilo. | |
| BR112015006828A8 (pt) | composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; uso do composto; e método para modular a atividade de uma proteína ire1 | |
| MX2013011922A (es) | Compuestos de benceno substituido. | |
| BR112013030894A2 (pt) | moduladores do sistema imune | |
| BR112015001502A2 (pt) | derivados de tipo azaindazol ou diazaindazol para tratamento de dor | |
| BR112015008480A2 (pt) | compostos de benzeno substituído | |
| BR112015022096A8 (pt) | compostos moduladores de canal de sódio, composição que os compreende e uso dos mesmos | |
| BR112013020586A2 (pt) | Uso de células derivadas de tecido do cordão umbilical | |
| WO2011121250A3 (fr) | Composition cosmetique et pharmaceutique comprenant de la n-acetyl-glucosamine- 6 - phosphate | |
| BR112014003071A2 (pt) | tratamento de doença vascular periférica com o uso de células derivadas do tecido do cordão umbilical | |
| BR112015010791A2 (pt) | moduladores de gpr40 de di-hidropirazol | |
| BR112013020159A2 (pt) | método para inibir células tumorais de hamartoma | |
| EA201590183A1 (ru) | Производные азаиндола, выступающие в качестве ингибиторов pi3k | |
| BR112015014367A2 (pt) | formulações inibidoras de lfa-1 | |
| BR112014029439A2 (pt) | derivados de ácido salicílico, sal farmaceuticamente aceitável dos mesmos, composição dos mesmos e método de uso dos mesmos | |
| BR112012031634A2 (pt) | composto, composição farmacêutica, uso de um composto, e método para tratar um paciente que sofre de ou susceptível a um distúrbio | |
| BR112012015984A2 (pt) | composição para melhorar a função cerebral, e, polipeptídeo | |
| BR112015022044A2 (pt) | um método de proporcionar neutroproteção ocular |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |